TIM-3 抑制剂:瘤免疫治疗的有希望的策略
Lu Lu1, Liufu Deng1
1Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Science, Shanghai Jiao Tong University, Shanghai 200240, China.
Trends in molecular medicine
|February 1, 2024
概括
研究人员发现了ML-T7,一种新的小分子抑制剂,向T细胞免疫球蛋白和含有粘素的分子3 (TIM-3). 在临床前模型中,这种化合物单独或与抗PD-1疗法一起显示出显著的抗瘤作用.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- T细胞免疫球蛋白和含有粘素的分子3 (TIM-3) 是一个重要的免疫检查点受体.
- 调节错误的TIM-3信号传递有助于瘤免疫逃避.
- 准TIM-3为癌症免疫治疗提供了一个有希望的策略.
研究的目的:
- 系统地选出抑制TIM-3.的FG-CC'裂的小分子化合物.
- 在临床前癌症模型中评估已识别的抑制剂的抗瘤疗效.
主要方法:
- 系统的小分子化合物选.
- 生物化学测定以评估TIM-3抑制.
- 在小鼠瘤模型中使用单剂和组合疗法的体内疗效研究.
主要成果:
- 功能性TIM-3抑制剂的鉴定,被指定为ML-T7.
- 作为单一药物,ML-T7表现出显著的抗瘤活性.
- 结合ML-T7与抗PD-1疗法,导致增强抗瘤反应.
结论:
- ML-T7是一种强大的TIM-3抑制剂,具有已证明的临床前抗瘤活性.
- 结合ML-T7和抗PD-1疗法,在癌症治疗中具有协同作用的潜力.
- ML-T7需要对癌症免疫治疗进行进一步的临床研究.
更多相关视频
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.6K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
760
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K